Based on our results showing that patients harboring concurrent NPM1, FLT3‐ITD, and DNMT3A mutations had the worst OS, these patients need to be scheduled for allogeneic hematopoietic stem cell transplantation in the early stage of AML. Here, NPM1 is linked to acute myeloid leukemia.